Tableaux’s AbbVie ABBV Stock Holding History

Tableaux’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,612	Closed	-$373K	–	89
2025 Q3	$373K	Buy	+1,612	New	+$328K	0.15%	86
2025 Q2	–	Sell	-1,034	Closed	-$217K	–	118
2025 Q1	$217K	Buy	+1,034	New	+$201K	0.16%	86

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Tableaux's ABBV Position: Q4 2025 in Review

Tableaux sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 1,612 shares — an estimated $373K sold.

Tableaux first reported a position in ABBV in Q1 2025 and held it in 2 quarters. The position peaked at $373K in Q3 2025. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Tableaux reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
Tableaux sold 1,612 AbbVie shares in Q4 2025, an estimated $373K.
Tableaux first reported a position in AbbVie in Q1 2025 and held it in 2 quarters.
Tableaux's AbbVie position peaked at $373K in Q3 2025.
4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Tableaux's 13F filing for Q4 2025, filed 13 Feb 2026.